Nisa Investment Advisors
ORKA

Nisa Investment Advisors’s Oruka Therapeutics ORKA Stock Holding History

Nisa Investment Advisors’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.8K Buy
702
+404
+136% +$26.9K ﹤0.01% 1740
2026
Q1 		$14.6K Buy
298
+16
+6% +$556 ﹤0.01% 2116
2025
Q4 		$8.55K Buy
+282
New +$7.86K ﹤0.01% 2290

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nisa Investment Advisors's ORKA Position: Q2 2026 in Review

Nisa Investment Advisors increased its Oruka Therapeutics (ORKA) stake by 136% in Q2 2026, buying an estimated $26.9K and bringing the position to 702 shares worth $66.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

Nisa Investment Advisors first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. 144 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Nisa Investment Advisors held 702 shares of Oruka Therapeutics worth $66.8K as of Q2 2026.
  • Nisa Investment Advisors bought 404 Oruka Therapeutics shares in Q2 2026, an estimated $26.9K.
  • Oruka Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1740 holding.
  • Nisa Investment Advisors first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 144 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.